-transparent.png){kind=logo}
A patient with refractory relapsed Hodgkin's disease underwent an autologous bone marrow transplant in July 1987 and achieved remission of Hodgkin's disease. He had complete hematological recovery but developed pancytopenia 3 years post bone marrow transplantation with morphological evidence of myelodysplasia. High-dose cyclophosphamide, 200 mg/kg, chemotherapy followed by an allogeneic bone marrow transplant from a HLA-matched sibling was performed in April 1991 with complete hematological recovery. Allogeneic bone marrow transplantation was thus used successfully to treat a potential complication of autologous bone marrow transplantation.
Related Publications
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
January 2000,
The Turkish journal of pediatrics,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
July 1993,
Blood,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
July 1990,
British journal of haematology,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
February 1994,
Bone marrow transplantation,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
October 2000,
Zhonghua nei ke za zhi,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
December 1989,
Bone marrow transplantation,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
April 1986,
New York state journal of medicine,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
November 1988,
Canadian family physician Medecin de famille canadien,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
September 1990,
Nihon rinsho. Japanese journal of clinical medicine,
S Bashir, and
P Cook, and
M Katz, and
A Mittelman, and
T Ahmed
July 2002,
Leukemia & lymphoma,
